Guangdong Winsun Bio-pharmaceutical Co.,Ltd Sustainability Profile
Guangdong Winsun Bio-pharmaceutical Co., Ltd., commonly referred to as Winsun, is a leading player in the biopharmaceutical industry, headquartered in Guangdong, China. Established in 2001, the company has made significant strides in the development and production of innovative biopharmaceutical products, focusing on areas such as biopharmaceutical research, manufacturing, and distribution. Winsun is renowned for its core offerings, which include advanced biologics and therapeutic solutions that cater to various medical needs. The company’s commitment to quality and innovation has positioned it as a trusted name in the market, with a strong presence in both domestic and international regions. Notable achievements include several industry certifications and partnerships that underscore its reputation for excellence in biopharmaceutical development.
DitchCarbon Score
How does Guangdong Winsun Bio-pharmaceutical Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Waste Composting industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guangdong Winsun Bio-pharmaceutical Co.,Ltd's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guangdong Winsun Bio-pharmaceutical Co.,Ltd's reported carbon emissions
Guangdong Winsun Bio-pharmaceutical Co., Ltd, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures. Consequently, there are no recorded emissions totals, including Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not established any documented reduction targets or climate commitments, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without these commitments or data, it is unclear how Guangdong Winsun Bio-pharmaceutical Co., Ltd plans to address its carbon footprint or contribute to climate action within the bio-pharmaceutical industry.
How Carbon Intensive is Guangdong Winsun Bio-pharmaceutical Co.,Ltd's Industry?
How Carbon Intensive is Guangdong Winsun Bio-pharmaceutical Co.,Ltd's Location?
Guangdong Winsun Bio-pharmaceutical Co.,Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangdong Winsun Bio-pharmaceutical Co.,Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
